id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2333-0008,FDA,FDA-2020-E-2333,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-04-05T04:00:00Z,2024,4,2024-04-05T04:00:00Z,,2024-04-05T18:36:28Z,,0,0,09000064864bd15a
FDA-2020-E-2333-0007,FDA,FDA-2020-E-2333,Letter from FDA CDER to U.S.  Patent and Trademark Office,Other,Letter(s),2024-01-25T05:00:00Z,2024,1,2024-01-25T05:00:00Z,,2024-01-25T14:46:33Z,,0,0,09000064863c1f74